[HTML][HTML] Risk and severity of SARS-CoV-2 reinfections during 2020–2022 in Vojvodina, Serbia: A population-level observational study
S Medić, C Anastassopoulou… - The Lancet Regional …, 2022 - thelancet.com
Background Data on the rate and severity of SARS-CoV-2 reinfections in real-world settings
are scarce and the effects of vaccine boosters on reinfection risk are unknown. Methods In a …
are scarce and the effects of vaccine boosters on reinfection risk are unknown. Methods In a …
[HTML][HTML] Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis
S Xu, J Li, H Wang, F Wang, Z Yin, Z Wang - BMC medicine, 2023 - Springer
Background The two inactivated SARS-CoV-2 vaccines, CoronaVac and BBIBP-CorV, have
been widely used to control the COVID-19 pandemic. The influence of multiple factors on …
been widely used to control the COVID-19 pandemic. The influence of multiple factors on …
[HTML][HTML] Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general …
M Law, SSH Ho, GKC Tsang, CMY Ho… - The Lancet Regional …, 2023 - thelancet.com
Background Inactivated, whole-virion vaccines have been used extensively in the SARS-
CoV-2 pandemic. Its efficacy and effectiveness across regions have not been systematically …
CoV-2 pandemic. Its efficacy and effectiveness across regions have not been systematically …
[HTML][HTML] Effectiveness and cost-effectiveness of inactivated vaccine to address COVID-19 pandemic in China: evidence from randomized control trials and real-world …
Y Fu, J Zhao, X Wei, P Han, L Yang, T Ren… - Frontiers in public …, 2022 - frontiersin.org
Objective This study aimed to determine the efficacy, effectiveness, and cost-effectiveness of
inactivated COVID-19 vaccines (CoronaVac and BBIBP-CorV) in China using existing …
inactivated COVID-19 vaccines (CoronaVac and BBIBP-CorV) in China using existing …
Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and …
X Zhang, J Xia, L Jin, Y Wu, X Zheng… - Human Vaccines & …, 2023 - Taylor & Francis
We aimed to evaluate the effectiveness or efficacy of heterologous or homologous COVID-
19 vaccine regimens against COVID-19-related outcomes after primary immunization with …
19 vaccine regimens against COVID-19-related outcomes after primary immunization with …
[HTML][HTML] COVID-19 breakthrough infections among patients aged≥ 65 years in Serbia: morbidity and mortality overview
MP Bajči, DF Lendak, M Ristić, MM Drljača, S Brkić… - Vaccines, 2022 - mdpi.com
Highlights What are the main findings? Case fatality ratio decrease and reduction of severe
and critical forms have been noted in fully vaccinated older individuals. Increasing age is still …
and critical forms have been noted in fully vaccinated older individuals. Increasing age is still …
[HTML][HTML] Immunogenicity of BNT162b2, BBIBP-CorV, Gam-COVID-Vac and ChAdOx1 nCoV-19 Vaccines Six Months after the Second Dose: A Longitudinal …
V Petrović, V Vuković, A Patić, M Marković, M Ristić - Vaccines, 2022 - mdpi.com
Many available SARS-CoV-2 vaccines demonstrated good humoral response, but studies
directly comparing their immunogenicity in the general population are lacking. We evaluated …
directly comparing their immunogenicity in the general population are lacking. We evaluated …
[HTML][HTML] Seroepidemiology of SARS-CoV-2 virus in healthcare workers before circulation of the omicron sublineages BA. 4/BA. 5 in Vojvodina, Serbia
M Ristić, V Vuković, A Patić, M Marković, V Petrović - Vaccines, 2022 - mdpi.com
Healthcare workers (HCWs) are a vulnerable and critical population in the ongoing
response to the SARS-CoV-2 pandemic. We aimed to estimate the seroprevalence in HCWs …
response to the SARS-CoV-2 pandemic. We aimed to estimate the seroprevalence in HCWs …
[HTML][HTML] Humoral immunoresponse elicited against an adenoviral-based SARS-CoV-2 coronavirus vaccine in elderly patients
RH Tomas-Grau, C Maldonado-Galdeano… - Aging (Albany …, 2022 - ncbi.nlm.nih.gov
The early sequencing of the SARS-CoV-2 viral genome allowed for a speedy development
of effective vaccines against the virus. Nevertheless, age-related immunosenescence, the …
of effective vaccines against the virus. Nevertheless, age-related immunosenescence, the …
[HTML][HTML] Epidemiological Characteristics of COVID-19 during Seven Consecutive Epidemiological Waves (2020–2022) in the North Bačka District, Serbia
J Banjac, V Vuković, T Pustahija, N Bohucki, DK Berić… - Viruses, 2023 - mdpi.com
The COVID-19 pandemic continues to pose a threat to global public health. The purpose of
this research was to determine the epidemiological characteristics of COVID-19 in the North …
this research was to determine the epidemiological characteristics of COVID-19 in the North …